ZYMEWORKS INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
ZYMEWORKS INC. (ZYME) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$129.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$129.00K, a 295.45% decline year-over-year.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$486.00K, a 189.01% decline year-over-year.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was -$29.00K.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $290.00K, a 84.78% decline year-over-year.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $873.00K.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was -$349.00K, a 723.21% decline from fiscal 2023.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $56.00K.
- ZYMEWORKS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $0.00.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$129.00K 10-Q · filed 2026-08-06 | -$615.00K 10-Q · filed 2026-08-06 | -$644.00K derived: sum of 3 quarters · filed 2026-08-06 | -$354.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$486.00K 10-Q · filed 2026-08-06 | -$515.00K derived: sum of 2 quarters · filed 2026-08-06 | -$225.00K derived: sum of 3 quarters · filed 2026-08-06 | -$159.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $261.00K derived: sum of 2 quarters · filed 2026-03-02 | $327.00K derived: sum of 3 quarters · filed 2026-08-06 | $873.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $290.00K 10-Q · filed 2025-11-06 | $356.00K derived: sum of 2 quarters · filed 2026-08-06 | $902.00K 10-Q · filed 2025-11-06 | -$51.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $66.00K 10-Q · filed 2026-08-06 | $612.00K 10-Q · filed 2026-08-06 | -$341.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $546.00K 10-Q · filed 2026-08-06 | -$407.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.50M derived: sum of 3 quarters · filed 2026-08-06 | $1.32M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | -$953.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $952.00K derived: sum of 2 quarters · filed 2026-03-02 | $772.00K derived: sum of 3 quarters · filed 2026-03-02 | -$349.00K 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.91M 10-Q · filed 2025-11-06 | $1.73M derived: sum of 2 quarters · filed 2025-11-06 | $604.00K 10-Q · filed 2025-11-06 | $2.30M derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-06-30 | -$180.00K 10-Q · filed 2025-11-06 | -$1.30M 10-Q · filed 2025-08-07 | $394.00K derived: sum of 3 quarters · filed 2026-03-02 | -$91.00K derived: sum of 4 quarters · filed 2026-03-02 |
| 2024-03-31 | -$1.12M 10-Q · filed 2025-11-06 | $574.00K derived: sum of 2 quarters · filed 2026-03-02 | $89.00K derived: sum of 3 quarters · filed 2026-03-02 | -$1.78M derived: sum of 4 quarters · filed 2026-03-02 |
| 2023-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $1.21M derived: sum of 2 quarters · filed 2026-03-02 | -$664.00K derived: sum of 3 quarters · filed 2026-03-02 | $56.00K 10-K · filed 2026-03-02 |
| 2023-09-30 | -$485.00K 10-Q · filed 2024-10-31 | -$2.36M derived: sum of 2 quarters · filed 2024-10-31 | -$1.64M 10-Q · filed 2024-10-31 | -$1.64M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | -$1.87M 10-Q · filed 2024-10-31 | -$1.15M 10-Q · filed 2024-08-01 | -$1.15M derived: sum of 3 quarters · filed 2025-03-05 | -$1.15M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $720.00K 10-Q · filed 2024-10-31 | $720.00K derived: sum of 2 quarters · filed 2025-03-05 | $720.00K derived: sum of 3 quarters · filed 2025-03-05 | $720.00K derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $0.00 derived: sum of 2 quarters · filed 2025-03-05 | $0.00 derived: sum of 3 quarters · filed 2025-03-05 | $0.00 10-K · filed 2025-03-05 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-10 | $0.00 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | |||
| 2021-12-31 | $0.00 10-K · filed 2024-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |